Tokyo Tape
Sign in
← Nipro

Quarterly report · Q3

8086.TEDINET S100Q5DE
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥406.3bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥494.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥369.4bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥13.2bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥19.7bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥13.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥27.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥20.6bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥14.7bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥19.1bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥7.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.0bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥8.1bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥12.2bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥1.05Tat 2022-12-31Cons.Assets
Total assets¥930.3bnat 2022-03-31Cons.Assets
Total assets¥902.8bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥809.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥730.5bnat 2022-03-31Cons.Liabilities
Net assets / equity¥240.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥199.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥193.7bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥102.7bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥95.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥42.692022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥4.352022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.682021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.92021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥37.822022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥77.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥64.772021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio21.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.9%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥530m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥166m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥28.6bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥22.5bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥318.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥314.2bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥30.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥70.3bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥53.6bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥16.8bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.2bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2022-04-01 → 2022-12-31¥42.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2022-04-01 → 2022-12-31¥38.0bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥431.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥405.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥25.9bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥35.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥434.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥406.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥28.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥35.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-12-31¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-12-31¥446m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-12-31¥1.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-12-31¥258m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥26.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥26.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥20.2bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥284.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥280.0bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥4.8bn
jpcrp040300-q3r_E02688-000Medical Treatment Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥31.0bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue2021-04-01 → 2021-12-31¥70.1bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue external2021-04-01 → 2021-12-31¥54.4bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15.7bn
jpcrp040300-q3r_E02688-000Medicine Relatedreportable segmentsegment profit2021-04-01 → 2021-12-31¥6.1bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue2021-04-01 → 2021-12-31¥39.1bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue external2021-04-01 → 2021-12-31¥34.5bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥4.6bn
jpcrp040300-q3r_E02688-000Pharma Packagingreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
—segment totalrevenue2021-04-01 → 2021-12-31¥394.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥368.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥25.1bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥39.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥396.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥369.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-12-31¥26.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥39.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 449
ItemContextValueUnit
Impairment loss elCurrentYTDDuration－JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration535000000JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration95000000JPY
Other elPrior1YTDDuration483000000JPY
Other elCurrentYTDDuration1463000000JPY
Extraordinary lossPrior1YTDDuration2018000000JPY
Extraordinary lossCurrentYTDDuration2782000000JPY
Income before income taxesPrior1YTDDuration19093000000JPY
Income before income taxesCurrentYTDDuration14724000000JPY
Income taxes currentPrior1YTDDuration5570000000JPY
Income taxes currentCurrentYTDDuration5649000000JPY
Income taxes deferredPrior1YTDDuration1333000000JPY
Income taxes deferredCurrentYTDDuration1008000000JPY
Income taxesPrior1YTDDuration6904000000JPY
Income taxesCurrentYTDDuration6658000000JPY
Profit lossPrior1YTDDuration12189000000JPY
Profit lossCurrentYTDDuration8065000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration1151000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration1103000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration11038000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration6962000000JPY
Profit lossPrior1YTDDuration12189000000JPY
Profit lossCurrentYTDDuration8065000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration2355000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-2859000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration21000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration55000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration11156000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration35845000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-78000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration383000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration199000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration2152000000JPY
Other comprehensive incomePrior1YTDDuration13654000000JPY
Other comprehensive incomeCurrentYTDDuration35577000000JPY
Comprehensive incomePrior1YTDDuration25843000000JPY
Comprehensive incomeCurrentYTDDuration43643000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration24393000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration42204000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration1450000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration1439000000JPY
Exporting notes receivable discountedPrior1YearInstant4000000JPY
Exporting notes receivable discountedCurrentQuarterInstant－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicalTreatmentRelatedReportableSegmentsMember280021000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000MedicineRelatedReportableSegmentsMember54351000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02688-000PharmaPackagingReportableSegmentMember34537000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember368909000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember446000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember369356000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass